Berlin, Germany: The administration of the non-psychoactive cannabinoid cannabidiol (CBD) increases adult neurogenesis (the active…
Region: Germany
Hurth, Germany: Researchers worldwide have performed 37 separate clinical trials assessing the therapeutic safety and…
Munich, Germany: The moderate use of cannabis and other psychoactive substances is not associated with…
Halle, Germany: Symptoms associated with so-called “cannabis withdrawal” among marijuana “dependent” subjects are relatively mild,…
Heidelberg, Germany: Oral administration of synthetic THC capsules (dronabinol) mitigates symptoms of attention deficit hyperactivity…
Berlin, Germany: Oral administration of synthetic THC capsules (dronabinol) mitigates symptoms in patients with treatment-resistance…
Bonn, Germany: Cannabinoids significantly reduce skin inflammation and may be ideal topical agents for treating…
Berlin, Germany: Cannabis use is associated with improved cognition in schizophrenic patients, according to clinical…